Armata Pharmaceuticals, Inc. (ARMP)
3.135
+0.08
(+2.45%)
USD |
NYAM |
Oct 22, 10:12
Armata Pharmaceuticals Net Income (Quarterly) : 74.14M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 74.14M |
| March 31, 2026 | -115.35M |
| December 31, 2025 | -124.30M |
| September 30, 2025 | -26.68M |
| June 30, 2025 | -16.30M |
| March 31, 2025 | -6.531M |
| December 31, 2024 | 2.60M |
| September 30, 2024 | -5.481M |
| June 30, 2024 | 8.986M |
| March 31, 2024 | -25.02M |
| December 31, 2023 | -19.85M |
| September 30, 2023 | -31.16M |
| June 30, 2023 | -3.547M |
| March 31, 2023 | -14.49M |
| December 31, 2022 | -10.31M |
| September 30, 2022 | -8.614M |
| June 30, 2022 | -9.215M |
| March 31, 2022 | -8.774M |
| December 31, 2021 | -6.047M |
| September 30, 2021 | -5.419M |
| June 30, 2021 | -6.194M |
| March 31, 2021 | -5.495M |
| December 31, 2020 | -6.624M |
| September 30, 2020 | -5.769M |
| June 30, 2020 | -4.71M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.078M |
| December 31, 2019 | -4.586M |
| September 30, 2019 | -6.955M |
| June 30, 2019 | -4.199M |
| March 31, 2019 | -3.739M |
| December 31, 2018 | -1.101M |
| September 30, 2018 | -2.771M |
| June 30, 2018 | -3.167M |
| March 31, 2018 | -3.134M |
| December 31, 2017 | -2.352M |
| September 30, 2017 | -0.779M |
| June 30, 2017 | -6.461M |
| March 31, 2017 | -3.246M |
| December 31, 2016 | -9.50M |
| September 30, 2016 | -3.589M |
| June 30, 2016 | -3.851M |
| March 31, 2016 | -3.112M |
| December 31, 2015 | -2.231M |
| September 30, 2015 | 5.439M |
| June 30, 2015 | 10.77M |
| March 31, 2015 | -14.49M |
| December 31, 2014 | 0.347M |
| September 30, 2014 | 21.21M |
| June 30, 2014 | 13.87M |
| March 31, 2014 | -12.03M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.51M |
| Total Expenses (Quarterly) | -71.63M |
| EPS Diluted (Quarterly) | -0.272 |
| Enterprise Value | 403.67M |
| Gross Profit Margin (Quarterly) | 76.45% |
| Earnings Yield | -242.0% |
| Normalized Earnings Yield | -135.63 |